Top

Supportive Care in Cancer

Published in:

01-10-2014 | Letter to the editor

Response to letter to the editor, “Predictors of falls among community-dwelling older adults with cancer: results from the health and retirement study”

Author: Tuo-Yu Chen

Published in: Supportive Care in Cancer | Issue 10/2014

Excerpt

To the Editor, …

Dharmarajan TS, Avula S, Norkus EP (2007) Anemia increases risk for falls in hospitalized older adults: an evaluation of falls in 362 hospitalized, ambulatory, long-term care, and community patients. J Am Med Dir Assoc 8:e9–e15PubMedCrossRef

Dharmarajan TS, Norkus EP (2004) Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc 5:395–400PubMedCrossRef

Extermann M, Overcash J, Lyman GH, Parr J, Balducci L (1998) Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16:1582–1587PubMed

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A: Biol Med Sci 56:M146–M157CrossRef

Rubenstein LZ, Josephson KR (2006) Falls and their prevention in elderly people: what does the evidence show? Med Clin N Am 90:807–824PubMedCrossRef

Tendas A, Niscola P, Cinque R, Cupelli L, Giovannini M, Ales M, Dentamaro T, Scaramucci L, de Fabritiis P (2010) Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. Leuk Res 34:e66PubMedCrossRef

Wade DT, Collin C (1988) The Barthel ADL Index: a standard measure of physical disability? Disabil Rehabil 10:64–67CrossRef

Title: Response to letter to the editor, “Predictors of falls among community-dwelling older adults with cancer: results from the health and retirement study”
Author: Tuo-Yu Chen
Publication date: 01-10-2014
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 10/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-014-2368-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2014

Erratum to: “We all talk about it as though we’re thinking about the same thing.” Healthcare professionals’ goals in the management of pain due to advanced cancer: a qualitative study

Mandatory communication skills training for oncologists: enforcement does not substantially impact satisfaction

Psychometric properties of scale constructed from the International Classification of Functioning, Disability and Health (ICF) core set for breast cancer based on Rasch analysis

Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients

Cancer-related fatigue: can it be due to adrenal suppression secondary to high-dose steroids used as antiemetic?

Desire for children, difficulties achieving a pregnancy, and infertility distress 3 to 7 years after cancer diagnosis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer